Clinical Trial Resource Center


Therapeutic Areas: Oncology | Hematology

Hematologic Neoplasms Clinical Trials


A listing of Hematologic Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Arizona

Scottsdale : Investigational Site Number 840003 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Scottsdale : Oncology Research Associates

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Scottsdale : Mayo Clinic Scottsdale-Phoenix

Patients are needed to participate in a clinical research study of EPZ-5676

Tucson : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Tucson : Arizona Oncology Associates

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Arkansas

Fayetteville : Highlands Oncology Group Highlands Oncology Group (22)

Patients are needed to participate in a clinical research study of LGX818 to evaluate Solid Tumor and Hematologic Malignancies

Little Rock : Call for Information (Investigational Site 0385) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Rogers : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

California

Anaheim : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Bakersfield : Call for Information (Investigational Site 0326) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Berkeley : Call for Information (Investigational Site 0015) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Burbank : Call for Information (Investigational Site 0324) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Campbell : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Corona : Call for Information (Investigational Site 0425) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Duarte : City of Hope

A Phase 2 clinical study for patients with Hematologic Malignancies

Duarte : City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1)

A Phase 2 clinical study for patients with Hematologic Neoplasms

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fair Oaks : Call for Information (Investigational Site 0380) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Fountain Valley : Call for Information (Investigational Site 0431) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Fresno : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Highland : Call for Information (Investigational Site 0430) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

La Jolla : Call for Information (Investigational Site 0251) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Los Angeles : Childrens Hospital Los Angeles

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Los Angeles : Cedars-Sinai Medical Center

A clinical trial to evaluate treatments using CC-115 for patients

Mission Hills : Call for Information (Investigational Site 0121) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Mission Hills : Call for Information (Investigational Site 0252) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Orange : Children's Hospital of Orange County

A Phase 1 clinical study for patients using human myeloid progenitor cells

Orange : Call for Information (Investigational Site 0433) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Palo Alto :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Pleasant Hill : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rancho Mirage : Call for Information (Investigational Site 0350) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Riverside : Call for Information (Investigational Site 0418) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

San Diego : Sharp Memorial Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Diego : UCSD Moores Cancer Research Institute

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

San Diego : Call for Information (Investigational Site 0354) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

San Francisco : Investigational Site Number 840005 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

San Francisco : University of California at San Francisco

A clinical trial to evaluate treatments using CC-115 for patients

Santa Barbara : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Santa Monica : Call for Information (Investigational Site 0344) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Stanford : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Stanford : Stanford School of Medicine

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Colorado

Aurora : Updated

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Aurora : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Aurora : Call for Information (Investigational Site 0444) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Boulder : Rocky Mountain Cancer Centers, LLP

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Denver : The Colorado Blood Cancer Institute

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Englewood : Call for Information (Investigational Site 0304) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Connecticut

New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine

A clinical research study for the treatment of Hematologic Malignancies

Norwalk : Whittingham Cancer Center Norwalk Hospital

Patients are needed to participate in a clinical research study of LGX818 to evaluate Solid Tumor and Hematologic Malignancies

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Delaware

Newark : Call for Information (Investigational Site 0274) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Wilmington : Alfred I. duPont Hospital for Children

A Phase 1 clinical study for patients using human myeloid progenitor cells

District of Columbia

Washington : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Washington : Children's National Medical Center

A Phase 1 clinical study for patients using human myeloid progenitor cells

Washington : Call for Information (Investigational Site 0309) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Florida

Boynton Beach : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Fort Myers : Florida Cancer - Colonial

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fort Myers : Florida Cancer Specialists Florida Cancer Specialists (31

Patients are needed to participate in a clinical research study of MEK162 to evaluate Solid Tumor and Hematologic Malignancies

Hollywood : Memorial Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Inverness : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Jacksonville : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Jacksonville : Mayo Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Jacksonville : Baptist Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lakeland : Call for Information (Investigational Site 0384) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Miami :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Miami : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Miami : Call for Information (Investigational Site 0284) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Miami : Call for Information (Investigational Site 0278) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Miami : Call for Information (Investigational Site 0340) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Miami : Call for Information (Investigational Site 0028) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Miami : Call for Information (Investigational Site 0243) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Orlando : Call for Information (Investigational Site 0419) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Port St. Lucie : Call for Information (Investigational Site 0259) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Sarasota : Florida Cancer Specialists

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Sarasota : TG Therapeutics Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Sarasota : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Stuart : Call for Information (Investigational Site 0339) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Tampa : Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using CC-115 for patients

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Tampa :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating Sodium Bicarbonate

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Georgia

Atlanta : Investigational Site Number 840009 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Atlanta : Winship Cancer Institute, Emory University

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Atlanta : Emory University-Winship Cancer Institute

A Phase 2 clinical study for patients with Hematologic Malignancies

Atlanta : Northside Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Augusta : Georgia Regents University SC-2

A Phase 2 clinical study for patients with Hematologic Neoplasms

Columbus : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lawrenceville : Gwinnett Hospital System Dba The Center for Cancer Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Marietta : Northwest Georgia Oncology Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Savannah : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Illinois

Chicago : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Chicago : University of Chicago Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Chicago : Rush University Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Chicago : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Chicago : Northwestern University

Patients are needed to participate in a clinical research study of EPZ-5676

Chicago : Call for Information (Investigational Site 0024) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Chicago : Call for Information (Investigational Site 0023) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Chicago : Call for Information (Investigational Site 0454) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Decatur : Call for Information (Investigational Site 0285) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Joliet : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Joliet : Call for Information (Investigational Site 0407) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Maywood : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

A Phase 1 clinical study for patients using human myeloid progenitor cells

Niles : Illinois Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Rockford : Call for Information (Investigational Site 0443) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Skokie : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Skokie : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Skokie : Call for Information (Investigational Site 0303) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Skokie : Call for Information (Investigational Site 0386) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Urbana : Call for Information (Investigational Site 0205) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Indiana

Anderson : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Anderson : Call for Information (Investigational Site 0025) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Avon : Call for Information (Investigational Site 0257) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Evansville : Call for Information (Investigational Site 0011) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Fort Wayne : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Indianapolis : Quality Oncology Care, Inc.

A clinical study for patients with Cancer, Solid Tumor or Hematologic Malignancy

Indianapolis : Community Regional Cancer Center-Community Hospital North

A clinical study for patients with Cancer, Solid Tumor or Hematologic Malignancy

Indianapolis : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Indianapolis : IU

Patients are needed to participate in a clinical research study evaluating TG02 citrate

Indianapolis : Call for Information (Investigational Site 0427) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Kokomo : Call for Information (Investigational Site 0442) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Martinsville : Morgan Hospital and Medical Center

A clinical study for patients with Cancer, Solid Tumor or Hematologic Malignancy

New Albany : Call for Information (Investigational Site 0396) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Iowa

Ames : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ames : Call for Information (Investigational Site 0249) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Cedar Rapids : Call for Information (Investigational Site 0360) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Cedar Rapids : Call for Information (Investigational Site 0286) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Des Moines : Call for Information (Investigational Site 0197) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Iowa City : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Waterloo : Call for Information (Investigational Site 0382) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Kansas

Fairway : Kansas University Medical Center

Patients are needed to participate in a clinical research study evaluating MLN9708 for the treatment of Advanced Solid Tumors or Hematologic Malignancies

Wichita : Call for Information (Investigational Site 0199) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Kentucky

Paducah : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Paducah : Call for Information (Investigational Site 0283) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Louisiana

Baton Rouge : Hematology Oncology Clinic, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Maine

Scarborough : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Maryland

Baltimore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Baltimore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Baltimore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Baltimore : University of Maryland, Greenebaum Cancer Center

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Baltimore : The Sidney Kimmel Comprehensive Cancer Center

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma, Hodgkin Lymphoma or Multiple Myeloma

Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with MDS, Leukemias or Lymphomas

Baltimore : Sidney Kimmel Comprehensive Cancer Center

A Phase 2 clinical study for patients with MDS, Leukemias or Lymphomas

Baltimore : Call for Information (Investigational Site 0247) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Bethesda : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Westminster : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Massachusetts

Boston : Tufts-New England Medical Center

A clinical research study for the treatment of Hematologic Malignancies

Boston : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Boston : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Boston : Dana Farber Cancer Institute

A Phase 1 clinical study for patients with Hematologic Neoplasms

Boston : Dana-Farber Cancer Institute

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma, Hodgkin Lymphoma or Multiple Myeloma

Boston : Massachusetts General Hospital

A Phase 2 clinical study for patients with Hematologic Malignancies

Boston : Dana-Farber Cancer Institute- Hematopoietic Stem Cell Transplant Program

A Phase 2 clinical study for patients with Hematologic Malignancies

Boston : Boston Children's Hospital

A Phase 2 clinical study for patients with Hematologic Malignancies

Boston : Dana Farber Cancer Institute SC-8

A Phase 2 clinical study for patients with Hematologic Neoplasms

Boston : Updated

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Boston : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Boston : Tufts Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Danvers : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Fairhaven : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Michigan

Ann Arbor : University of Michigan

A Phase 2 clinical study for patients with Hematologic Malignancies

Ann Arbor : University of Michigan Health System

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Grand Rapids : Spectrum Health

A clinical trial to evaluate treatments using Cohort 1-Bortezomib (Velcade ®), Cohort 2-Bortezomib (Velcade ®) and Cohort 3-Bortezomib (Velcade ®) for patients with Hematological Malignancy

Grand Rapids : Call for Information (Investigational Site 0423) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Lansing : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Minnesota

Duluth : Call for Information (Investigational Site 0282) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

A Phase 1 clinical study for patients using human myeloid progenitor cells

Minneapolis : Novartis Investigative Site

A Phase 1/Phase 2 clinical study for patients using HSC835

Minneapolis : Call for Information (Investigational Site 0022) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Rochester : Mayo Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma, Hodgkin Lymphoma or Multiple Myeloma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

St. Cloud : Call for Information (Investigational Site 0202) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Woodbury : Minnesota Oncology Hematology, PA

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Mississippi

Hattiesburg : Hattiesburg Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jackson : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Missouri

Springfield : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

St. Louis : Washington University School of Medicine Division of Oncology

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

St. Louis : Washington University School of Medicine

A Phase 1/Phase 2 clinical study for patients with Leukemia, Lymphoma or Multiple Myeloma

St. Louis : Washington University School of Medicine

A Phase 2 clinical study for patients with Hematologic Malignancies

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

St. Louis : Call for Information (Investigational Site 0150) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Montana

Billings : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Billings : Call for Information (Investigational Site 0368) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Great Falls : Call for Information (Investigational Site 0378) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Missoula : Call for Information (Investigational Site 0349) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Nebraska

Lincoln : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Omaha : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Omaha : Oncology Hematology West PC dba Nebraska Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Omaha : Call for Information (Investigational Site 0256) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Nevada

Las Vegas : Call for Information (Investigational Site 0387) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

North Las Vegas : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

New Jersey

Hackensack : Investigational Site Number 840011 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Hackensack : John Theurer Cancer Center at Hackensack University

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments using SNX-5422 for patients with Cancer

Hackensack : TG Therapeutics Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Hackensack : HUMC

Patients are needed to participate in a clinical research study evaluating TG02 citrate

Hackensack : Hackensack University Medical Center

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Morristown : Hematology Oncology Associates of Northern New Jersey

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Somerville : Call for Information (Investigational Site 0327) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

New York

Bronx : Call for Information (Investigational Site 0201) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Commack : Call for Information (Investigational Site 0263) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

East Syracuse : Call for Information (Investigational Site 0033) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Great Neck : Call for Information (Investigational Site 0258) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Lake Success : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lake success : Call for Information (Investigational Site 0234) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Lake Success : Call for Information (Investigational Site 0230) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Manhasset : Call for Information (Investigational Site 0233) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

New York : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

New York : Mount Sinai Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : Weill Cornell-New York Presbyterian Hospital

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : TG Therapeutics Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

New York : Memorial Sloan Kettering Cancer Ctr

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma, Hodgkin Lymphoma or Multiple Myeloma

New York : Mount Sinai Hospital

A Phase 2 clinical study for patients with Hematologic Malignancies

New York : Updated

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

New York : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of EPZ-5676

New York : Weill Cornell Medical Center

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Rochester : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rochester : Call for Information (Investigational Site 0198) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Stony Brook : Research Site

A clinical research study of Arm 1- Dose Escalation and Arm 2- Dose Expansion for the treatment of Cancer, Hematologic Malignancies, Leukemia or Myeloid Leukemia

Stony Brook : Call for Information (Investigational Site 0254) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Valhalla : Westchester Medical Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

North Carolina

Asheville : Call for Information (Investigational Site 0342) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Durham : Duke University Medical Center

A clinical research study of NiCord® for the treatment of Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Durham : TG Therapeutics Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Durham : Duke Cancer Institute

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Durham : Duke University Health System

Patients are needed to participate in a clinical research study of EPZ-5676

Goldsboro : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

High Point : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Winston-Salem : Call for Information (Investigational Site 0315) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

North Dakota

Fargo : Call for Information (Investigational Site 0301) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Fargo : Call for Information (Investigational Site 0153) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Ohio

Akron : Call for Information (Investigational Site 0323) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Akron : Call for Information (Investigational Site 0250) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Canton : Gabrail Cancer Center

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Canton : Call for Information (Investigational Site 0422) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Cincinnati : Oncology Hematology Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cleveland : Research Site

A clinical research study of Arm 1- Dose Escalation and Arm 2- Dose Expansion for the treatment of Cancer, Hematologic Malignancies, Leukemia or Myeloid Leukemia

Cleveland : Case Western

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Cleveland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Cleveland : Cleveland Clinic, Taussig Cancer Institute

A Phase 1 clinical study for patients using human myeloid progenitor cells

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cleveland : University Hospitals of Cleveland

Patients are needed to participate in a clinical research study evaluating MLN9708 for the treatment of Advanced Solid Tumors or Hematologic Malignancies

Columbus : Nationwide Children's Hospital

A Phase 1 clinical study for patients using human myeloid progenitor cells

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 2 clinical study for patients with Hematologic Malignancies

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : OSU

Patients are needed to participate in a clinical research study evaluating TG02 citrate

Columbus : The Ohio State University

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Columbus : Ohio State University Comprehensive Cancer Center - The James

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Oklahoma

Oklahoma City : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Oklahoma City : Oklahoma University

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Oregon

Portland : Oregon Health Sciences

A Phase 2 clinical study for patients with Hematologic Malignancies

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Springfield : Williamette Valley Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Pennsylvania

Bethlehem : Call for Information (Investigational Site 0417) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Hershey : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Philadelphia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Philadelphia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Philadelphia : Call for Information (Investigational Site 0447) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Philadelphia : Call for Information (Investigational Site 0026) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

West Reading : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

West Reading : Call for Information (Investigational Site 0016) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

South Carolina

Charleston : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Charleston : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Charleston : Call for Information (Investigational Site 0316) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Greenville : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

South Dakota

Aberdeen : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rapid City : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rapid City : Call for Information (Investigational Site 0241) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Sioux Falls : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sioux Falls : Call for Information (Investigational Site 0151) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Watertown : Prairie Lakes Health Care System, Inc.

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Watertown : Call for Information (Investigational Site 0225) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Tennessee

Germantown : Jones Clinic PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Memphis : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Memphis : St. Jude Children's Research Hospital

A Phase 1 clinical study for patients with Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Acute Leukemia

Nashville : Investigational Site Number 840001 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Nashville : Tennessee Oncology, PLLC

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

A clinical trial to evaluate treatments using CC-115 for patients

Nashville : Tennessee Oncology, PLLC

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Nashville : Vanderbilt-Ingram Cancer Center

A clinical trial to evaluate treatments using SNX-5422 for patients with Cancer

Nashville : TG Therapeutics Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Nashville : Updated

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Nashville : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Nashville : SCRI

Patients are needed to participate in a clinical research study evaluating TG02 citrate

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of EPZ-5676

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Texas

Amarillo : Call for Information (Investigational Site 0295) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Arlington : Arlington Cancer Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Austin : Texas Oncology-Austin Midtown

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Austin : Call for Information (Investigational Site 0404) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Corpus Christi : Call for Information (Investigational Site 0406) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Corpus Christi : Call for Information (Investigational Site 0372) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using CC-115 for patients

Dallas : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : Texas Oncology-Medical City Dallas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Dallas : Mary Crowley Cancer Research Center

Patients are needed to participate in a clinical research study evaluating MLN9708 for the treatment of Advanced Solid Tumors or Hematologic Malignancies

Dallas : Texas Oncology, P.A. Presbyterian Hospital (3)

Patients are needed to participate in a clinical research study of MEK162 to evaluate Solid Tumor and Hematologic Malignancies

Dallas : Call for Information (Investigational Site 0366) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Fort Worth : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Galveston : Call for Information (Investigational Site 0027) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Houston : Research Site

A clinical research study of Arm 1- Dose Escalation and Arm 2- Dose Expansion for the treatment of Cancer, Hematologic Malignancies, Leukemia or Myeloid Leukemia

Houston : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Houston : M D Anderson Cancer Center New

A clinical trial seeking patients for a research study for the treatment of AML, CMML or MDS

Houston : The University of Texas, MD Anderson Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Houston :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Houston : The University Of Texas Md Anderson Cancer Center

A Phase 1 clinical study for patients with Hematologic Neoplasms

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating MLN9708 for the treatment of Advanced Solid Tumors or Hematologic Malignancies

Houston : UT MD Anderson Cancer

Patients are needed to participate in a clinical research study of EPZ-5676

Killeen : Call for Information (Investigational Site 0314) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Lubbock : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

New Braunfels : Call for Information (Investigational Site 0441) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Round Rock : Call for Information (Investigational Site 0245) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

San Antonio : Methodist Hospital - Texas Transplant Institute

A clinical research study for the treatment of Hematologic Malignancies

San Antonio : South Texas Accelerated Research Therapeutics

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma or Waldenstrom Macroglobulinemia

San Antonio : Texas Transplant Center at Methodist Healthcare System

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

San Antonio : Cancer Care Network of South Texas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Antonio : Methodist Healthcare System

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

San Antonio : Call for Information (Investigational Site 0317) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Temple : Call for Information (Investigational Site 0343) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Temple : Call for Information (Investigational Site 0034) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Utah

Ogden : Call for Information (Investigational Site 0239) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Salt Lake City : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Salt Lake City : Investigational Site Number 840002 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Salt Lake City : Call for Information (Investigational Site 0313) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Virginia

Christiansburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Fairfax : Virginia Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Richmond : Virginia Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Washington

Everett : Call for Information (Investigational Site 0440) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Kennewick : Columbia Basin Hematology and Oncology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seattle : Investigational Site Number 840012 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Seattle : Seattle Cancer Care Alliance

A Phase 1 clinical study for patients with Hematologic Neoplasms

Seattle : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Seattle : University of Washington

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Seattle : Call for Information (Investigational Site 0013) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Spokane : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Spokane : Evergreen Hematology and Oncology

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Tacoma : Northwest Medical Specialties NW Medical Specialties

Patients are needed to participate in a clinical research study of MEK162 to evaluate Solid Tumor and Hematologic Malignancies

Tacoma : Call for Information (Investigational Site 0029) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Vancouver : Northwest Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Wenatchee : Call for Information (Investigational Site 0428) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Yakima : Yakima Valley Memorial Hospital North Star Lodge

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

West Virginia

Morgantown : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Wisconsin

Green Bay : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Green Bay : Call for Information (Investigational Site 0122) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

La Crosse : Call for Information (Investigational Site 0236) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Madison : Call for Information (Investigational Site 0311) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Milwaukee : TG Therapeutics Investigational Trial Site

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Milwaukee : Medical College of Wisconsin

A Phase 1 clinical study for patients using human myeloid progenitor cells

Australia

Adelaide :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Clayton : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Coburg : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Darlinghurst : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Douglas : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

East Melbourne : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Epping : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hobart : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hobart : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Liverpool : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study of GSK2110183 to evaluate Cancer

Parkville : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Prahran : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Prahran :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Queensland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

South Brisbane : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Tweed Heads : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Westmead :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Wodonga : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Austria

Innsbruck : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Krems an der Donau : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Salzburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Wien : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Belgium

Antwerpen : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Bruges : Algemeen Ziekenhuis Sint-Jan

A clinical research study of ATIR for the treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Brugge : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Brussels : Université Libre de Bruxelles - Institute Jules Bordet

A clinical research study of ATIR for the treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Brussels : MSD Belgium BVBA/SPRL Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Bruxelles : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Hasselt : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Louvain : Universitair Ziekenhuis Gasthuisberg

A clinical research study of ATIR for the treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Brazil

Sao Paulo : MSD Brasil Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Bulgaria

Pleven : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Plovdiv : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sofia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sofia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sofia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sofia : Merck Sharp & Dohme Bulgaria EOOD Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Varna : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Canada

Barrie : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Barrie : Royal Victoria Regional Health Centre

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Burnaby : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Calgary : Tom baker Cancer Centre

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Halifax : Queen Elizabeth II Health Sciences Centre

A clinical trial to evaluate treatments using Anti-Thymocyte Globulin (Rabbit) and Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) for patients with Hematologic Malignancies

Halifax : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Hamilton : Juravinsky Hospital and Cancer Centre

A clinical research study of ATIR for the treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Hamilton : Juravinski Hospital & Cancer Centre

A clinical trial to evaluate treatments using Anti-Thymocyte Globulin (Rabbit) and Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) for patients with Hematologic Malignancies

Laval : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Moncton : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Montreal : Maisonneuve-Rosemont Hospital

A clinical research study of ATIR for the treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Montreal : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Montreal : Hopital Maisonneuve-Rosemont

A clinical trial to evaluate treatments using Anti-Thymocyte Globulin (Rabbit) and Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) for patients with Hematologic Malignancies

Montreal : Sir Mortimer B. Davis-Jewish General Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Montréal : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Newmarket : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Oshawa : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Quebec : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Saint John : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Sault Ste. Marie : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

St. Johns : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toronto : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toronto : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toronto : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study of GSK2110183 to evaluate Cancer

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Vancouver : Vancouver General Hospital

A clinical trial to evaluate treatments using Anti-Thymocyte Globulin (Rabbit) and Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) for patients with Hematologic Malignancies

Windsor : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Winnipeg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Winnipeg : CancerCare Manitoba

A clinical trial to evaluate treatments using Anti-Thymocyte Globulin (Rabbit) and Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) for patients with Hematologic Malignancies

Colombia

Bogota : MDS Colombia SAS Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Czech Republic

Brno : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ostrava-Poruba : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Plzen : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Denmark

Copenhagen : Rigshospitalet

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Hematological Malignancies

Estonia

Tallinn : Merck Sharp & Dohme OU Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Finland

Helsinki : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Tampere : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

France

Amiens Cedex 1 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Avignon Cedex 9 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Creteil : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Le Kremlin Bicetre : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Le Mans : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Le Mans Cedex 9 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lille : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lille : CHRU Lille

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Lyon : Centre Hospitalier Lyon Sud

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Lyon Cédex 3 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Marseille cedex 5 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Marseille Cedex 9 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Mulhouse : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Nantes Cedex 01 : Investigational Site Number 250003 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Nantes Cedex 1 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nantes cedex 1 : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Paris : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Paris : Hopital Saint Louis

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Paris : MSD France Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Paris Cedex 12 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Paris Cedex 14 : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Périgueux cedex : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Pierre Benite : Investigational Site Number 250004 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Pierre-Benite cedex : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Pontoise Cedex : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rouen : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rouen cedex 1 : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Saint Quentin : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Strasbourg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toulouse : Investigational Site Number 250001 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Villefranche Sur Saone Cedex : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Villejuif : Gustave Roussy

A clinical research study of Crizotinib for the treatment of Hematologic Cancers, Solid Tumors or Metastatic Cancer

Villejuif : Department of Medical Oncology-Institut Gustave Roussy

A clinical trial to evaluate treatments using CC-115 for patients

Villejuif : Updated

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Villejuif : Updated

Patients are needed to participate in a clinical research study evaluating AG-221 for the treatment of Relapsed and/or Primary Refractory AML as Defined by WHO Criteria, Untreated AML, ≥60 Years of Age and Not a Candidate for Standard Therapy or Recurrent or Refractory Myelodysplastic Syndrome

Germany

Ahaus : Facharzt für Innere Medizin, Onkologie, Hämatologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Bad Sackingen : "Facharzt für Innere Medizin

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Berlin : Onkoplan GmbH/Onkologische Schwerpunkpraxis

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Berlin : MediOnko-Institut GbR

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Bonn : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Chemnitz : FA f. Frauenheilkunde und Geburtshilfe Gynakolgische Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Dortmund : Gesellschaft für onkologische Studien Dortmund mbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Dresden : Gemeinschaftspraxis

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Dusseldorf : Gemeinschaftspraxis Haematologie/Medizin Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Essen : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Garbsen : Internist - Hämatologe - Onkologe

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Gutersloh : Onkodok GmbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Haar : Merck Sharp & Dohme GmbH Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Hamburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hannover : Internist - Hämatologe - Onkologe

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Heidenheim : ODZ-Petersen GmbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Herne : DOKUSAN Gesellschaft für medizinische Studien mbH & Co. KG

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Koeln : Uniklinik Koln

A clinical trial to evaluate treatments using CC-115 for patients

Köln : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Krefeld : ZAGO

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Leipzig : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Leipzig : Pneumologisch/onkologisch/internistisches Studienzentrum

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Lepzig : FA f. Frauenheilkunde und Geburtshilfe

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Lippstadt : Fachübergreifende Gemeinschaftspraxis Innere Medizin, Hämatologie, Onkologie, Tumortherapie, Palliativmedizin

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Mainz : Praxis für Innere Medizin, Hämatologie und Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Minden : Johannes Esling Klinikum Minden

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Moers : OnkoLog Moers GbR

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Munchen : Forschungs- und Studiengesellschaft HOPE München GmbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Munchen : Fachärzte für Innere Medizin - Hämatologie u. Internistische Onkologie - Bluttransfusionswesen

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Münster : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Neustadt/Sachsen : Facharzt für Innere Medizin - Medikamentöse Tumortherapie - Palliativmedizin

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Nordhausen : MVZ Nordhausen gGmbH/ FA für Frauenheilkunde und Geburtshilfe

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Nurnberg : Martha-Maria Krankenhaus gGmbH MVZ Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Oeide : Fachärztin für Innere Medizin Hämatologie u. Internistische Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Olpe : Medizinisches Versorgungszentrum Onkologische Schwerpunktpraxis

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Osnabruck :

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Paradiese : Medizinisches Versorgungszentrum GbR

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Remscheid : Facharzt für Innere Medizin - Hämatologie - Onkologie - Medikamentöse Tumortherapie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Rodgau : Frauenärzte -Naturheilverfahren-

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Siegburg : Onkol. Managementgesellschaft Bonn/Rhein-Sieg/Ahr mbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Stralsund : g.SUND Gyn. Kompetenzzentrum FA f. Frauenheilkunde & Geburtshilfe SP Gynäkologie Onkologie operative Gyn./ med. Tumortherapie/ Palliativmed.

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Ulm : Universitätsklinikum Ulm

Patients are needed to participate in a clinical research study of EPZ-5676

Velbert : Fachärzte für Innere Medizin -Hämatologie und Internistische Onkologie

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Witten : FA f. Frauenheilkunde u. Geburtshilfe Marien-Hospital Witten gGmbH

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Zittau : FA für innere Medizin/Hämatologie und Int. Onkologie/Palliativmedizin

Patients are needed to participate in a clinical research study to evaluate Solid Tumor, Malignant Hematological Tumor or Primary or Secondary Prophylactic Treatment

Greece

Athens : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Athens : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Athens : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Heraklion : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Patra : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Thessaloniki : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hong Kong

Hong Kong : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hong Kong : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

New Territories : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hungary

Budapest : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Budapest : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Debrecen : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Gyula : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kaposvar : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Szeged : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ireland

Co-Limerick : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Dublin : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Dublin : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Dublin : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Tullamore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Italy

Ancona : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Bari : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Brescia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Catania : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Firenze : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Genova : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Meldola (FC) : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Milano : Rhizen Trial Site

Patients are needed to participate in a clinical research study evaluating RP6530 for the treatment of Lymphoma, B-Cell or T-Cell Lymphoma

Napoli : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Napoli : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Novara : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Novara : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Palermo : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Pisa : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Roma : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Roma : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Rome : MSD Italia S.r.l. Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Torino : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Torino : Ospedale Molinette

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Udine : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Udine : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Vimercate MB : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Japan

Akita-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Chuo-ku : Pfizer Investigational Site

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia

Fukuoka : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Fukuoka : Pfizer Investigational Site

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia

Fukuoka-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Isehara : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Kamogawa-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kawagoe-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kobe-city : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kobe-shi : Pfizer Investigational Site

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia

Kumamoto-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kyoto-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Maebashi-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nagoya-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nagoya-shi : Research site

A Phase 1 clinical study for patients with Blood Cancer or Advanced B Cell Malignancies

Ogaki-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Okayama-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Shibukawa-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Shibuya-ku : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Shinjuku-ku : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Tokushima-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Toyama-shi : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Jordan

Amman : MSD Idea, Inc. - LB BR Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Korea, Republic of

Anyang : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Busan : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Busan : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Daegu : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Daegu : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Daejeon : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Gwangju : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Incheon : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Incheon : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Jellanamdo : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Jeonju : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Kyunggi-do : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Seoul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Seoul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Seoul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Seoul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Seoul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Seoul : Seoul National University Hospital

A Phase 2 clinical study for patients with Oral Mucositis

Seoul : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Seoul : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Lebanon

Beirut : MSD Idea, Inc. - LB BR Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Lithuania

Kaunas : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Vilnius : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Malaysia

Ampang : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Georgetown : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ipoh : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kuching : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Netherlands

Amsterdam : Teva Investigational Site 38045

Patients are needed to participate in a clinical research study evaluating omacetaxine mepesuccinate for the treatment of Hematologic Malignancies or Solid Tumors

Rotterdam : Erasmus University Medical Center

Patients are needed to participate in a clinical research study of EPZ-5676

Utrecht : University Medical Centre Utrecht

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

New Zealand

Christchurch : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Christchurch : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Grafton, Auckland : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Hamilton : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Panama

Panama : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Peru

Lima : Merck Sharp & Dohme, Peru S.R.L. Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Philippines

Makati : Merck Sharp & Dohme (I.A.) Corporation Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Poland

Chorzow : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Legnica : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lublin : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Opole : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Slupsk : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Slupsk : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Torun : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Warszawa : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Warszawa : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Wroclaw : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Portugal

Braga : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Coimbra : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lisboa : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Matosinhos : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Porto : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Puerto Rico

San Juan : Call for Information (Investigational Site 0098) Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Russian Federation

Ekaterinburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Moscow : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nizhny Novgorod : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Novosibirsk : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Petrozavodsk : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Saint-Petersburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Saint-Petersburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Samara : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Saratov : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

St. Petersburg : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Volgograd : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Singapore

Singapore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Singapore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Singapore : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Singapore : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Slovakia

Bratislava : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nitra : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Nove Zamky : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

South Africa

Midrand : MSD (Pty) LTD South Africa Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Spain

Badalona : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Barcelona : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Barcelona : Hospital Universitario Vall Hebrón

A clinical trial to evaluate treatments using CC-115 for patients

Barcelona : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Madrid : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Madrid : Unidad de Fase I 3º planta Hospital Universitario Madrid Sanchinarro

A clinical trial to evaluate treatments using CC-115 for patients

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Madrid : Merck Sharp and Dohme de Espana S.A. Updated

Patients are needed to participate in a clinical research study of V212 and Placebo to evaluate Herpes Zoster

Majadahonda (Madrid) : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Móstoles : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Ourense : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Palma de Mallorca : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Pamplona : Investigational Site Number 724002 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

Pozuelo de Alarcón/Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Salamanca : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Salamanca : Investigational Site Number 724001 Updated

A clinical trial seeking patients for a research study for the treatment of Hematological Malignancy

San Sebastian : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

San Sebastian : Hospital de Donosti

A clinical trial to evaluate treatments using CC-115 for patients

Santander : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Sevilla : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sevilla : Pasillo Onco-Hematología. Sala de Protocolos Hospital Universitario Virgen del Rocío

A clinical trial to evaluate treatments using CC-115 for patients

Valencia : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Sweden

Eskilstuna : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Karlskrona : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Malmö : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Uppsala : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Switzerland

Basel : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Basel : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating KRP203 for the treatment of Hematological Malignancies

Bellinzona : IOSI

Patients are needed to participate in a clinical research study of OTX015 to evaluate Acute Leukemia or Other Hematological Malignacies

Chur : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Zurich : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Zurich : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taiwan

Changhua : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kaohsiung : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taichung : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taichung : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taichung : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Tainan : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taipei : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taipei : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Taoyuan : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Taoyuan Hsien : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Turkey

Ankara : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ankara : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Ankara : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Istanbul : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Izmir : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ukraine

Cherkasy : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Dnepropetrovsk : ul.Gazety Pravda 96

Prognostic Potential Cell Surface Marker and Pim-kinase in Patients With Hematologic Malignancies or Solid Tumors

Dnipropetrovsk : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Ivano-Frankivsk : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Khmelnitskiy : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Kyiv : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Lviv : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Poltava : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

United Kingdom

Airdrie : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Belfast : Northern Ireland Cancer Trials Centre - Queen's University Belfast TriaIs Centre

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Bournemouth : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Cardlff : Velindre Hospital

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Glasgow : Beatson West of Scotland Cancer Centre

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Harrow : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Headington, Oxford : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Leeds : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

London : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

London : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

London : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Newcastle : Sir Bobby Robson Cancer Trials Research Centre

Patients are needed to participate in a clinical research study of Carfilzomib to evaluate Solid Tumors, Hematologic Malignancies or Hepatic Impairment

Orpington : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Oxford : Research Site Updated

A clinical research study of Denosumab and Zoledronic acid

Swindon : GSK Investigational Site

A Phase 3 clinical study for patients with Herpes Zoster Vaccine

Stay Informed
Sign up for e-newsletters, major
events and research alerts!

3520 Lake Ave., Ste 202, Wilmette, IL 60091 | Office: 847.424.0600 | Fax: 847.424.0606 | Contact Us